Screener
Denali Therapeutics Inc. DNLI Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashAndCashEquivalentsNoncurrent.
The source filing: Denali Therapeutics Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:08 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001714899-26-000097
FAQ
- What is Denali Therapeutics Inc.'s restricted cash?
- Denali Therapeutics Inc. (DNLI) reported restricted cash of $3.1M in Q2 2026.
- How has Denali Therapeutics Inc.'s restricted cash changed year-over-year?
- Denali Therapeutics Inc.'s restricted cash decreased by 0.0% year-over-year, from $3.1M to $3.1M.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about Denali Therapeutics Inc.'s restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude